ALB and kidney disorder: Binding is increased when NEFA are decreased by insulin,nicotinic acid or other antilipolytic agents, but is decreased by displacementfrom albumin-binding sites by NEFA and agents acting via NEFA, by directdisplacement, e.g. by salicylate, or if [albumin] is decreased, e.g. inpregnancy and liver and kidney diseases.